Dermatological conditions contribute to approximately 1.79% of the global burden of diseases.1 According to the American Academy of Dermatology (AAD), 1 in 4 Americans has skin conditions.2 Acne, psoriasis, rosacea, and vitiligo are the most common conditions managed by dermatologists.3 While some skin conditions are transient, others may begin in childhood and continue into adulthood.…
How To Treat
Despite the significant impact of hidradenitis suppurativa on quality of life, treatment options are limited. This article reviews the current understanding of the diagnosis and management of this debilitating, chronic condition.
Inhibition of IL-23 may have added benefits in the treatment of psoriasis. This review covers Il-23 antagonists for the treatment of Il-23 including guselkumab, risankizumab, and tildrakizumab.